BO-DCA is a high-volume deoxycholic acid (DCA) injectable from Quivermedic, sold in a 30 ml vial and positioned for body fat reduction across multiple sessions. DCA is a bile acid that disrupts fat-cell membranes. This is a medical procedure for a licensed professional, never a DIY shortcut.

What is BO-DCA, and what is deoxycholic acid?

BO-DCA is a lipolytic, an injectable meant to break down small pockets of fat. Its active ingredient is deoxycholic acid, a substance your own body already makes. Deoxycholic acid is a naturally occurring bile acid that helps emulsify dietary fat in the gut. When it is injected into fatty tissue, it disrupts the membranes of fat cells, and the manufacturer positions BO-DCA for body contouring.

The number that defines this product is its size. A 30 ml vial is large, which signals body-area positioning rather than a small facial touch-up. That scale is exactly where honest caution matters most, so it is worth reading the regulatory picture before anything else.

Log Notes. This page explains what BO-DCA is and the general science behind deoxycholic acid. It gives no doses, volumes, injection sites, depths, session counts, or technique. Those belong to a licensed professional and the official guide, not a blog. Nothing here is medical advice, and injectable lipolysis is never a do-it-yourself procedure.

Is this FDA-approved, and what are the risks?

Here is the honest headline. Deoxycholic acid is the one fat-dissolving ingredient with FDA approval, sold as Kybella, but that approval covers only fat under the chin (submental fat), not the body. So high-volume body use of any DCA product, including BO-DCA, is off-label, and these Korean lipolytics are generally not FDA-approved at all.

The regulator is direct about the broader category. The U.S. Food and Drug Administration warns that fat-dissolving injections that are not FDA-approved can be harmful, and that the agency cannot vouch for their safety, quality, or effectiveness. Injectable lipolysis carries real risks, swelling, bruising, nodules, nerve injury, and uneven results among them. Treat the manufacturer’s body-contouring positioning as marketing, and treat the FDA caution as the part that protects you.

What would a careful record look like?

A complete, dated one. Injectable lipolysis is typically discussed as a course rather than a single visit, and any changes show up slowly over weeks, so memory is a poor substitute for a log. If you ever pursue this with a licensed professional, a private record captures what was done, when, and how the area actually changed.

That is the role Dosefi plays. You log each session with its date and a photo, set a reminder for any review window your provider gives you, and self-rate the treated area so a real timeline replaces guesswork over the following weeks. A log never makes a procedure safe; it just keeps your own history honest and organized.

Because so many of these products share the same active ingredient, reading widely helps you ask better questions. Our notes on the DCA brand Kabelline and the carnitine-blend lipolytic Red Line show how similar, and how differently positioned, these formulas can be.

A grounded takeaway

BO-DCA is a 30 ml deoxycholic acid lipolytic positioned for body fat across several sessions. The honest bottom line is regulatory: deoxycholic acid is FDA-approved only for under-chin fat as Kybella, body use is off-label, and the FDA warns that non-approved fat-dissolving injections can be harmful. This is a medical decision for a licensed professional, never a DIY route. The official guide is attached for your records only.

Sources